66 related articles for article (PubMed ID: 18314626)
1. [GIPC: a new target for therapy in pancreatic adenocarcinoma?].
Muders MH; Baretton GB; Aust DE; Dutta SK; Wang E; Ikeda Y; Spaller MR; Datta K; Mukhopadhyay D
Verh Dtsch Ges Pathol; 2007; 91():286-93. PubMed ID: 18314626
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma.
Muders MH; Dutta SK; Wang L; Lau JS; Bhattacharya R; Smyrk TC; Chari ST; Datta K; Mukhopadhyay D
Cancer Res; 2006 Nov; 66(21):10264-8. PubMed ID: 17079444
[TBL] [Abstract][Full Text] [Related]
3. Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth.
Muders MH; Vohra PK; Dutta SK; Wang E; Ikeda Y; Wang L; Udugamasooriya DG; Memic A; Rupasinghe CN; Baretton GB; Aust DE; Langer S; Datta K; Simons M; Spaller MR; Mukhopadhyay D
Clin Cancer Res; 2009 Jun; 15(12):4095-103. PubMed ID: 19509165
[TBL] [Abstract][Full Text] [Related]
4. GIPC gene family (Review).
Katoh M
Int J Mol Med; 2002 Jun; 9(6):585-9. PubMed ID: 12011974
[TBL] [Abstract][Full Text] [Related]
5. 5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis.
Awan A; Lucic MR; Shaw DM; Sheppard F; Westwater C; Lyons SA; Stern PL
Biochem Biophys Res Commun; 2002 Jan; 290(3):1030-6. PubMed ID: 11798178
[TBL] [Abstract][Full Text] [Related]
6. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
7. Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.
Patra CR; Rupasinghe CN; Dutta SK; Bhattacharya S; Wang E; Spaller MR; Mukhopadhyay D
ACS Chem Biol; 2012 Apr; 7(4):770-9. PubMed ID: 22292614
[TBL] [Abstract][Full Text] [Related]
8. RGS19 enhances cell proliferation through its C-terminal PDZ motif.
Tso PH; Wang Y; Wong SY; Poon LS; Chan AS; Wong YH
Cell Signal; 2010 Nov; 22(11):1700-7. PubMed ID: 20599498
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
[TBL] [Abstract][Full Text] [Related]
11. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation.
Taniguchi K; Momiyama N; Ueda M; Matsuyama R; Mori R; Fujii Y; Ichikawa Y; Endo I; Togo S; Shimada H
Anticancer Res; 2008; 28(3A):1559-63. PubMed ID: 18630511
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.
Moser C; Schachtschneider P; Lang SA; Gaumann A; Mori A; Zimmermann J; Schlitt HJ; Geissler EK; Stoeltzing O
Eur J Cancer; 2008 Jul; 44(11):1577-86. PubMed ID: 18445520
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.
Sagiv E; Starr A; Rozovski U; Khosravi R; Altevogt P; Wang T; Arber N
Cancer Res; 2008 Apr; 68(8):2803-12. PubMed ID: 18413748
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
15. GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP.
De Vries L; Lou X; Zhao G; Zheng B; Farquhar MG
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12340-5. PubMed ID: 9770488
[TBL] [Abstract][Full Text] [Related]
16. RGS-GAIP-interacting protein controls breast cancer progression.
Wang L; Lau JS; Patra CR; Cao Y; Bhattacharya S; Dutta S; Nandy D; Wang E; Rupasinghe CN; Vohra P; Spaller MR; Mukhopadhyay D
Mol Cancer Res; 2010 Dec; 8(12):1591-600. PubMed ID: 21047775
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
18. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.
Pal K; Pletnev AA; Dutta SK; Wang E; Zhao R; Baral A; Yadav VK; Aggarwal S; Krishnaswamy S; Alkharfy KM; Chowdhury S; Spaller MR; Mukhopadhyay D
Mol Cancer Ther; 2014 Oct; 13(10):2264-75. PubMed ID: 25125675
[TBL] [Abstract][Full Text] [Related]
20. GAIP-interacting protein, C-terminus is involved in the induction of zinc-finger protein 143 in response to insulin-like growth factor-1 in colon cancer cells.
Paek AR; You HJ
Mol Cells; 2011 Nov; 32(5):415-9. PubMed ID: 21909943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
